NCLEX Review Guide: Increased Intracranial Pressure (IICP)

Understanding Intracranial Pressure

• Intracranial pressure (ICP) is the pressure exerted by the cranial contents including brain tissue (80%), cerebrospinal fluid (10%), and blood (10%) within the rigid skull. Normal ICP ranges from 5-15 mmHg in adults, with sustained pressures above 20 mmHg considered pathological.
• The Monro-Kellie doctrine states that the cranial vault is a fixed space, and an increase in volume of one component must be offset by a decrease in another to maintain normal pressure. When compensatory mechanisms fail, intracranial hypertension develops.

Causes of IICP

• Space-occupying lesions: Tumors, abscesses, hematomas (epidural, subdural, intracerebral), and cerebral edema occupy space within the cranium, directly increasing pressure.
• CSF circulation disorders: Hydrocephalus (obstructive or communicating) increases CSF volume, leading to elevated pressure throughout the ventricular system and subarachnoid space.
• Cerebral edema: Vasogenic (increased BBB permeability), cytotoxic (cellular swelling), interstitial (transependymal CSF flow), or osmotic causes lead to increased brain water content and volume.
• Vascular disorders: Cerebral hemorrhage, infarction, venous sinus thrombosis, and hypertensive encephalopathy can all disrupt normal cerebral blood flow and increase ICP.

Cushing's Triad

• Cushing's triad is a late sign of IICP consisting of: (1) increased systolic blood pressure with widening pulse pressure, (2) bradycardia, and (3) irregular respiratory pattern. This represents a critical neurological emergency indicating brainstem compression.
• The physiological basis involves the medulla's response to ischemia, triggering systemic hypertension to maintain cerebral perfusion pressure (CPP) while vagal stimulation causes bradycardia.

Classic Signs and Symptoms

• Early signs: Headache (worse with Valsalva maneuvers), nausea/vomiting (often projectile and unrelated to food), altered mental status (confusion, restlessness, irritability), and subtle personality changes may be the first indicators of rising ICP.
• Ocular changes: Pupillary abnormalities (sluggish reaction to light, unilateral dilation), diplopia (cranial nerve VI palsy), papilledema (optic disc swelling visible on fundoscopic exam), and visual disturbances are common findings.
• Late signs: Decreased level of consciousness progressing to coma, decerebrate or decorticate posturing, fixed and dilated pupils, and Cheyne-Stokes or ataxic breathing patterns indicate severe IICP requiring immediate intervention.

Neuroimaging

• CT scan is the initial diagnostic modality of choice for suspected IICP due to its rapid availability, ability to detect acute hemorrhage, hydrocephalus, mass lesions, and midline shift. CT findings may show ventricular compression, sulci effacement, and loss of gray-white differentiation.
• MRI provides superior tissue characterization and may be used for further evaluation once the patient is stabilized. MRI is particularly valuable for identifying posterior fossa lesions, small tumors, and cerebral edema patterns not clearly visible on CT.

ICP Monitoring

• Intraventricular catheter (EVD) is the gold standard for ICP monitoring, allowing both measurement and therapeutic CSF drainage. The catheter is placed in the lateral ventricle and connected to a transducer system and drainage apparatus.
• Other monitoring devices include parenchymal monitors (inserted directly into brain tissue), subarachnoid bolts, and epidural sensors, each with varying degrees of accuracy and risk profiles.
• Continuous ICP monitoring allows calculation of cerebral perfusion pressure (CPP = MAP - ICP), with a target of 60-70 mmHg to ensure adequate brain perfusion.

Additional Assessments

• Neurological assessment: Serial evaluations using the Glasgow Coma Scale (GCS), pupillary responses, and motor function help track clinical progression. Declining GCS score, especially a drop of 2 or more points, warrants immediate attention.
• Laboratory studies: CBC, coagulation studies, electrolytes, glucose, and toxicology screening may identify contributing factors. Arterial blood gases help assess oxygenation and ventilation status, which can impact cerebral blood flow.

Immediate Interventions

1. Airway management: Ensure patent airway and adequate oxygenation. Intubation may be necessary for patients with GCS ≤8 or deteriorating respiratory status. During intubation, prevent ICP spikes by premedication with lidocaine (1.5 mg/kg IV) and avoiding hypercarbia.
2. Position patient with head elevated 30-45 degrees (unless contraindicated) and in neutral alignment to promote venous drainage and reduce ICP. Avoid neck flexion, extension, or rotation that may impede jugular venous outflow.
3. Osmotic therapy: Administer mannitol (0.25-1 g/kg IV) or hypertonic saline (3% or 7.5%) as prescribed to reduce cerebral edema through osmotic fluid shifts. Monitor serum osmolality (target 310-320 mOsm/L) and electrolytes during osmotic therapy.
4. CSF drainage: If an EVD is in place, drain CSF according to protocol to maintain ICP below target thresholds (typically <20 mmHg). Maintain sterile technique during all EVD manipulations to prevent infection.

Ongoing Nursing Care

• Neurological monitoring: Perform frequent neurological assessments (every 1-2 hours or more often if unstable), including GCS, pupillary response, motor function, and vital signs. Document and report any deterioration immediately.
• ICP management: Minimize activities that increase ICP, including clustering nursing activities to provide rest periods. Avoid Valsalva maneuvers by preventing constipation and limiting suctioning to ≤10 seconds with pre-oxygenation.
• Temperature control: Maintain normothermia as hyperthermia increases cerebral metabolic demands and can worsen ICP. Implement cooling measures for temperatures >38°C (100.4°F) as prescribed.
• Seizure prevention: Administer prophylactic anticonvulsants as ordered and monitor for subtle signs of seizure activity, which can significantly increase ICP and cause secondary brain injury.

EVD Management

1. Maintain the drainage system at the prescribed level (typically at the level of the foramen of Monro, identified as the external auditory meatus or tragus of the ear).
2. Monitor drainage amount, color, and characteristics hourly. Normal CSF is clear and colorless; cloudy or bloody drainage requires immediate reporting.
3. Ensure the system is properly leveled and zeroed per hospital protocol, typically every shift and after any patient position change.
4. Never flush an EVD catheter or irrigate the system, as this can introduce infection or increase ICP.
5. Maintain a closed, sterile system and change dressings according to hospital protocol using strict aseptic technique.

Osmotic Diuretics

• Mannitol (0.25-1 g/kg IV) creates an osmotic gradient that pulls water from brain tissue into the vascular space, reducing cerebral edema. Effects begin within 15-30 minutes and last 4-6 hours. Monitor for rebound ICP elevation, electrolyte imbalances, and dehydration. Contraindicated in renal failure.
• Hypertonic saline (3% or 7.5% NaCl) reduces cerebral edema through osmotic effects and improves cerebral blood flow rheology. May be preferred over mannitol in hypovolemic patients. Monitor for hypernatremia, fluid overload, and central pontine myelinolysis with rapid sodium correction.

Sedatives and Analgesics

• Propofol reduces cerebral metabolic rate, cerebral blood flow, and ICP while allowing for rapid neurological assessment upon discontinuation. Monitor for hypotension, hypertriglyceridemia, and propofol infusion syndrome with prolonged high-dose use.
• Benzodiazepines (midazolam, lorazepam) provide sedation and seizure prophylaxis but may accumulate with prolonged use, delaying neurological assessment. Use with caution in elderly or hepatically impaired patients.
• Opioid analgesics (fentanyl, remifentanil) provide pain control with minimal hemodynamic effects. Short-acting agents are preferred to allow neurological assessment. Monitor for respiratory depression, especially when combined with other sedatives.

Other Medications

• Corticosteroids (dexamethasone) reduce vasogenic edema associated with tumors and some inflammatory conditions but have limited benefit in traumatic brain injury. Monitor for hyperglycemia, gastrointestinal bleeding, and increased infection risk.
• Anticonvulsants (levetiracetam, phenytoin) are used prophylactically in high-risk patients to prevent seizures, which can dramatically increase ICP. Monitor phenytoin levels (target 10-20 mcg/mL) and adjust dosing accordingly.
• Vasopressors (norepinephrine, phenylephrine) may be needed to maintain adequate CPP (target 60-70 mmHg) when hypotension occurs. Titrate carefully to avoid excessive hypertension, which may worsen cerebral edema.

Priority Nursing Interventions

• NCLEX questions often focus on priority setting in IICP scenarios. Remember that airway, breathing, and circulation always take precedence, followed by interventions to reduce ICP.
• When answering questions about IICP, consider the timing of interventions. For example, elevating the head of bed and ensuring proper alignment should be implemented before administering medications like mannitol.
• For questions about EVD management, remember that maintaining system sterility and proper positioning are always priorities, and the drainage system should never be flushed.

Recognizing Critical Changes

• NCLEX questions often present subtle changes that indicate worsening IICP. Be alert for questions that include pupillary changes, declining GCS scores, or changes in vital signs consistent with Cushing's triad.
• When presented with multiple assessment findings, identify those that require immediate intervention. For example, a fixed and dilated pupil is more urgent than a moderate headache.
• Know the progression of IICP signs from early (headache, nausea, subtle mental status changes) to late (Cushing's triad, posturing, fixed pupils) to identify the severity of the situation.

Common Pitfalls